Evidence map›Paper›PMID 33425942›Full record

ArticleFrontiers in medicine2020

Humidified Warmed CO

Alaa M M El-Betany, Enas M Behiry, Mark Gumbleton, Keith G Harding

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Carbon dioxide and MAPK signalling: towards therapy for inflammation.Cell communication and signaling : CCS · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Humidified Warmed COFrontiers in medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alaa M M El-BetanySchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Enas M BehirySchool of Medicine, Institute of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Mark GumbletonSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Keith G HardingWound Healing Research Unit, Welsh Wound Innovation Centre, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Cardiff University · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The coronavirus disease (COVID-19) outbreak has presented enormous challenges for healthcare, societal, and economic systems worldwide. There is an urgent global need for a universal vaccine to cover all SARS-CoV-2 mutant strains to stop the current COVID-19 pandemic and the threat of an inevitable second wave of coronavirus. Carbon dioxide is safe and superior antimicrobial, which suggests it should be effective against coronaviruses and mutants thereof. Depending on the therapeutic regime, CO

Indexed as

anti-COVID-19anti-cytokine stormantiviralcarrier gas compositionenhancer antiviralimprove COVID-19 symptomsprotect and improve organs functionsuppression COVID-19 pandemic

Identifiers

PMID33425942
PMCPMC7793941
OpenAlexW3111557224

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.